Diphtheria Therapeutics Pipeline Analysis 2018

Posted by Manish Kumar on July 25th, 2019

Diphtheria is an infectious and vaccine preventable disease caused by Corynebacterium diphtheriae. It is generally characterized by upper respiratory tract infection, and the most common sites for this disease are pharynx and tonsils. 

Download the sample report @ https://www.pharmaproff.com/request-sample/1059

Some of the symptoms include fever, sore throat, swollen glands, and weakness. Corynebacterium diphtheriae is a gram-positive bacterium that carries a gene for diphtheria toxin. 

Get the detailed analysis @ https://www.pharmaproff.com/report/diphtheria-therapeutics-pipeline-analysis

Most of the strains of the bacterium require pantothenic acid and nicotinic acid for their growth. According to the morphology, bacterium is classified into three biotypes; gravis, mitis, and intermedius.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidaDiphtheria is an infectious and vaccine preventable disease caused by Corynebacterium diphtheriae. It is generally characterized by upper respiratory tract infection, and the most common sites for this disease are pharynx and tonsils. Some of the symptoms include fever, sore throat, swollen glands, and weakness. Corynebacterium diphtheriae is a gram-positive bacterium that carries a gene for diphtheria toxin. Most of the strains of the bacterium require pantothenic acid and nicotinic acid for their growth. According to the morphology, bacterium is classified into three biotypes; gravis, mitis, and intermedius.